GFAP and migraine disorder: Regardless of why t-Tau protein elevation occurs in migraine patients, the lack of difference in concentrations of other biomarkers of neuroaxonal degeneration such as NfL, GFAP and UCHL1 needs to be emphasized and refutes major neurodegenerative processes in migraine.